GENova is a biotechnological drug development company with a strict focus on identifying, evaluating and acquiring new promising drugs for treatment and prevention of oncological and infectious diseases in human beings.

Each and every product candidate targets problem areas with considerable unmet need and ditto market potential. Subsequent inexpensive value-addition benefits both patients and stakeholders.

Fully developed our efficient programmes are then transferred to larger organizations, these being either other biotech companies and/or Big Pharma with infrastructures large enough to bring the products to market in a big scale.

Genova Biotherapeutics, Inc.
1461 A. First Ave.
#360
New York, NY 10021-2209

Stock Symbol: GVBP

Website: http://www.genovabio.com/

Post Sponsored By:
The Penny Stocks To Watch www.thepennystockstowatch.com
Pinnacle IR www.pinnacle-ir.com